1. DDX53 Promotes Cancer Stem Cell-Like Properties and Autophagy
   Hyuna Kim et al, 2017, Molecules and Cells CrossRef
2. Celastrol-mediated autophagy regulation in cancer
   Muhammad Haroon et al, 2020, Applied Biological Chemistry CrossRef
3. Celastrol inhibits angiogenesis and the biological processes of MDA-MB-231 cells via the DEGS1/S1P signaling pathway
   Lulu Jia et al, 2024, Biological Chemistry CrossRef
4. Transferrin-functionalised microemulsion co-delivery of β-elemene and celastrol for enhanced anti-lung cancer treatment and reduced systemic toxicity
   Qian Zhang et al, 2019, Drug Delivery and Translational Research CrossRef
5. Saikosaponin-d, a calcium mobilizing agent, sensitizes chemoresistant ovarian cancer cells to cisplatin-induced apoptosis by facilitating mitochondrial fission and G2/M arrest
   Hideaki Tsuyoshi et al, 2017, Oncotarget CrossRef
6. Improving Dissolution Properties by Polymers and Surfactants: A Case Study of Celastrol
   Jun Zha et al, 2018, Journal of Pharmaceutical Sciences CrossRef
7. Polyphenols and their benefits: A review
   Hassan Rasouli et al, 2017, International Journal of Food Properties CrossRef
8. Cyclic AMP induction of Dictyostelium prespore gene expression requires autophagy
   Yoko Yamada et al, 2019, Developmental Biology CrossRef
9. Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth
   Nan Yao et al, 2020, Signal Transduction and Targeted Therapy CrossRef
10. Axl is a novel target of celastrol that inhibits cell proliferation and migration, and increases the cytotoxicity of gefitinib in EGFR mutant non‑small cell lung cancer cells
    Youn Lee et al, 2019, Molecular Medicine Reports CrossRef
11. Hypoxia-induced autophagy promotes EGFR loss in specific cell contexts, which leads to cell death and enhanced radiosensitivity
    Baocai Liu et al, 2019, The International Journal of Biochemistry & Cell Biology CrossRef
12. Pomiferin targets SERCA, mTOR, and P-gp to induce autophagic cell death in apoptosis-resistant cancer cells, and reverses the MDR phenotype in cisplatin-resistant tumors in vivo
    Yuan-Qing Qu et al, 2023, Pharmacological Research CrossRef
13. Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment
    Jorge A.R. Salvador et al, 2017, European Journal of Medicinal Chemistry CrossRef
14. Autophagy in the pharmacological activities of celastrol (Review)
    Caixia Zhang et al, 2023, Experimental and Therapeutic Medicine CrossRef
15. Exploring the combined anti-cancer effects of sodium butyrate and celastrol in glioblastoma cell lines: a novel therapeutic approach
    Bahar Kartal et al, 2024, Medical Oncology CrossRef
16. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
    Daniel J. Klionsky et al, 2021, Autophagy CrossRef
17. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies
    Cheng Wang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
18. EGFR Family Members’ Regulation of Autophagy Is at a Crossroads of Cell Survival and Death in Cancer
    Elizabeth Henson et al, 2017, Cancers CrossRef
19. Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway
    Yingjun Zhu et al, 2020, Frontiers in Pharmacology CrossRef
20. Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression
    Raffaele Strippoli et al, 2024, Cancers CrossRef
21. Synthesis, computational docking and biological evaluation of celastrol derivatives as dual inhibitors of SERCA and P-glycoprotein in cancer therapy
    Paolo Coghi et al, 2021, European Journal of Medicinal Chemistry CrossRef
22. Natural products for combating multidrug resistance in cancer
    Ting Chen et al, 2024, Pharmacological Research CrossRef